Cargando…

LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients

OBJECTIVE: Amyotrophic lateral sclerosis (ALS) and myasthenia gravis (MG) are caused, respectively, by motor neuron degeneration and neuromuscular junction (NMJ) dysfunction. The membrane protein LRP4 is crucial in the development and function of motor neurons and NMJs and LRP4 autoantibodies have b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tzartos, John S, Zisimopoulou, Paraskevi, Rentzos, Michael, Karandreas, Nikos, Zouvelou, Vasiliki, Evangelakou, Panagiota, Tsonis, Anastasios, Thomaidis, Thomas, Lauria, Giuseppe, Andreetta, Francesca, Mantegazza, Renato, Tzartos, Socrates J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212481/ https://www.ncbi.nlm.nih.gov/pubmed/25356387 http://dx.doi.org/10.1002/acn3.26

Ejemplares similares

Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders
por: Tzartos, John S., et al.
Publicado: (2013)

Immunological and Structural Characterization of Titin Main Immunogenic Region; I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis
por: Stergiou, Christos, et al.
Publicado: (2023)

Novel Cell-Based Assay for Alpha-3 Nicotinic Receptor Antibodies Detects Antibodies Exclusively in Autoimmune Autonomic Ganglionopathy
por: Karagiorgou, Katerina, et al.
Publicado: (2022)

Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease
por: Vakrakou, Aigli G., et al.
Publicado: (2023)

Humoral immune activation in amyotrophic lateral sclerosis patients
por: Rentzos, Michael, et al.
Publicado: (2013)

Dental follicle mesenchymal stem cell administration ameliorates muscle weakness in MuSK-immunized mice
por: Ulusoy, Canan, et al.
Publicado: (2015)

Analysis of nAChR Autoantibodies Against Extracellular Epitopes in MG Patients
por: Michail, Maria, et al.
Publicado: (2022)

Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics
por: Lazaridis, Konstantinos, et al.
Publicado: (2020)

Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management
por: Lazaridis, Konstantinos, et al.
Publicado: (2020)

Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases: What Do Glomerulonephritis, Pemphigus Vulgaris, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura and Autoimmune Encephalitis Have in Common?
por: Koneczny, Inga, et al.
Publicado: (2021)

Neuroimaging data indicate divergent mesial temporal lobe profiles in amyotrophic lateral sclerosis, Alzheimer's disease and healthy aging
por: Christidi, Foteini, et al.
Publicado: (2019)

Hippocampal Metabolic Alterations in Amyotrophic Lateral Sclerosis: A Magnetic Resonance Spectroscopy Study
por: Christidi, Foteini, et al.
Publicado: (2023)

A Comparison of Two Analytical Approaches for the Quantification of Neurofilament Light Chain, a Biomarker of Axonal Damage in Multiple Sclerosis
por: Pafiti, Anna, et al.
Publicado: (2023)

Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients
por: Kordas, Gregory, et al.
Publicado: (2014)

Structural Insights into the Role of β3 nAChR Subunit in the Activation of Nicotinic Receptors
por: Giastas, Petros, et al.
Publicado: (2022)

Genotyping and Plasma/Cerebrospinal Fluid Profiling of a Cohort of Frontotemporal Dementia–Amyotrophic Lateral Sclerosis Patients
por: Bourbouli, Mara, et al.
Publicado: (2021)

Plasma P-Tau181 for the Discrimination of Alzheimer’s Disease from Other Primary Dementing and/or Movement Disorders
por: Tzartos, John S., et al.
Publicado: (2022)

IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies
por: Koneczny, Inga, et al.
Publicado: (2022)

Recent Advances in Genetic Predisposition of Myasthenia Gravis
por: Zagoriti, Zoi, et al.
Publicado: (2013)

Potential Role of Antibodies against Aquaporin-1 in Patients with Central Nervous System Demyelination
por: Pechlivanidou, Maria, et al.
Publicado: (2023)

A Recombinant Acetylcholine Receptor α1 Subunit Extracellular Domain Is a Promising New Drug Candidate for Treatment Of Myasthenia Gravis
por: Lazaridis, Konstantinos, et al.
Publicado: (2022)

Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
por: Farsalinos, Konstantinos, et al.
Publicado: (2020)

Cerebral Amyloid Angiopathy—Related Inflammation: A Single-Center Experience and a Literature Review
por: Theodorou, Aikaterini, et al.
Publicado: (2022)

Delayed Leucoencephalopathy as a Complication after Endovascular Therapy of Intracranial Aneurysms—A Case Series
por: Bakola, Eleni, et al.
Publicado: (2023)

Genetics of Myasthenia Gravis: A Case-Control Association Study in the Hellenic Population
por: Zagoriti, Zoi, et al.
Publicado: (2012)

Crystal Structure of the Monomeric Extracellular Domain of α9 Nicotinic Receptor Subunit in Complex With α-Conotoxin RgIA: Molecular Dynamics Insights Into RgIA Binding to α9α10 Nicotinic Receptors
por: Zouridakis, Marios, et al.
Publicado: (2019)

Nicotinic cholinergic system and COVID-19: In silico identification of interactions between α7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins
por: Lagoumintzis, George, et al.
Publicado: (2021)

Corrigendum: Crystal structure of the monomeric extracellular domain of α9 nicotinic receptor subunit in complex with α-conotoxin RgIA: Molecular dynamics insights into RgIA binding to α9α10 nicotinic receptors
por: Zouridakis, Marios, et al.
Publicado: (2022)

Clinical and Radiological Markers of Extra-Motor Deficits in Amyotrophic Lateral Sclerosis
por: Christidi, Foteini, et al.
Publicado: (2018)

The Clinical and Radiological Spectrum of Hippocampal Pathology in Amyotrophic Lateral Sclerosis
por: Christidi, Foteini, et al.
Publicado: (2018)

CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis
por: Gray, Elizabeth, et al.
Publicado: (2020)

PheWAS and cross-disorder analysis reveal genetic architecture, pleiotropic loci and phenotypic correlations across 11 autoimmune disorders
por: Topaloudi, Apostolia, et al.
Publicado: (2023)

Elevated Levels of IFN-γ in CSF and Serum of Patients with Amyotrophic Lateral Sclerosis
por: Liu, Juan, et al.
Publicado: (2015)

Global alterations to the choroid plexus blood-CSF barrier in amyotrophic lateral sclerosis
por: Saul, J., et al.
Publicado: (2020)

Modeling and Bioinformatics Identify Responders to G-CSF in Patients With Amyotrophic Lateral Sclerosis
por: Johannesen, Siw, et al.
Publicado: (2021)

Alterations of the serum and CSF ferritin levels and the diagnosis and prognosis of amyotrophic lateral sclerosis
por: Paydarnia, Parastou, et al.
Publicado: (2021)

Targeting amyotrophic lateral sclerosis by neutralizing seeding-competent TDP-43 in CSF
por: Audrain, Mickael, et al.
Publicado: (2023)

Expression of a Highly Antigenic and Native-Like Folded Extracellular Domain of the Human α1 Subunit of Muscle Nicotinic Acetylcholine Receptor, Suitable for Use in Antigen Specific Therapies for Myasthenia Gravis
por: Niarchos, Athanasios, et al.
Publicado: (2013)

Two Putative Polysaccharide Deacetylases Are Required for Osmotic Stability and Cell Shape Maintenance in Bacillus anthracis
por: Arnaouteli, Sofia, et al.
Publicado: (2015)

A Striational Muscle Antigen and Myasthenia Gravis-Associated Thymomas Share an Acetylcholine-Receptor Epitope
por: Marx, Alexander, et al.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_05baagiposq106a4kq7sho40he